title: Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment.
abstract: Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel aggregation-promoting property on the 350-kDa huntingtin protein. Using specific antibodies, we have probed the structure of the polyglutamine segment in mutant huntingtin complexes formed in cell culture from either truncated or full-length protein. Complexes formed by a mutant amino terminal fragment most frequently entail a change in conformation that eliminates reactivity with the polyglutamine-specific mAb 1F8, coincident with production of insoluble aggregate. By contrast, complexes formed by the full-length mutant protein remain soluble and are invariably 1F8-reactive, indicating a soluble polyglutamine conformation. Therefore, aggregates in HD may form by different biochemical mechanisms that invoke different possibilities for the pathogenic process. If pathogenesis is triggered by a truncated fragment, it probably involves the formation of an insoluble aggregate. However, the observation of soluble complexes in which an HD-specific pathogenic conformation of the glutamine tract remains accessible suggests that pathogenesis could also be triggered at the level of full-length huntingtin by abnormal aggregation with normal or abnormal protein partners.
authors.affiliation: Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, Massachusetts, 02129, USA.
authors.forename: F
authors.initials: F
authors.lastname: Persichetti
authors.forename: F
authors.initials: F
authors.lastname: Trettel
authors.forename: C C
authors.initials: CC
authors.lastname: Huang
authors.forename: C
authors.initials: C
authors.lastname: Fraefel
authors.forename: H T
authors.initials: HT
authors.lastname: Timmers
authors.forename: J F
authors.initials: JF
authors.lastname: Gusella
authors.forename: M E
authors.initials: ME
authors.lastname: MacDonald
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D002460:Cell Line; D002478:Cells, Cultured; D003342:Corpus Striatum / Q000378:metabolism*; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D009687:Nuclear Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D010455:Peptides / Q000737:chemistry*; D011487:Protein Conformation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D020449:Repetitive Sequences, Amino Acid; D012995:Solubility; D014162:Transfection
chemical_list: D000911:Antibodies, Monoclonal; C086055:HTT protein, human; C499524:Htt protein, rat; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D010446:Peptide Fragments; D010455:Peptides; D011994:Recombinant Proteins; C097188:polyglutamine